Nitinotes Announces Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center Clinical Site Activation in the EASE™ IDE Trial

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Nitinotes-Site-EASE

More Like This

PR Newswire associated0

Nitinotes Announces First Study Procedures at Orlando Health in the EASE™ IDE Trial

Nitinotes Announces First Patient Treated in Pivotal EASE™ Clinical Trial Evaluating the EndoZip™ Automated Suturing System for ESG

Nitinotes Announces FDA IDE Approval to Initiate Pivotal U.S. Trial of the EndoZip™ System for Endoscopic Sleeve Gastroplasty

Nitinotes Receives CE Mark Approval of EndoZip™, the First Fully Automated Suturing System for Endoscopic Sleeve Gastroplasty

Nitinotes Announces First Commercial EndoZip™ Procedures in Spain

Nitinotes Expands European Commercial Adoption with First Commercial EndoZip™ Cases Performed in France

ACCESSWIRE associated3

Nitinotes Surgical in Full Swing: Impressive Board Appointment, Over 90 Patients Treated, 400+ Sutures Performed, and a $10.1M Series B Funding Round Closure

PR Newswire associated0

Nitinotes Appoints Lloyd Diamond as Chief Executive Officer